 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Everwell Health Solutions |
| Street 1: | 5E, Fifth Floor, Rich Homes |
| Street 2: | Richmond Road |
| City: | Bangalore |
| Province: | |
| Post Code: | 560025 |
| Country: | India |
| Phone: | +917406998967 |
| Organization Email: | andrew@everwell.org |
| Web Site: | http://everwell.org |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Private sector |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Private Sector |
| Organization Type - Secondary: | Company |
| Organization Description: | |
| Everwell is a Bangalore-based social enterprise that designs and champions patient-centric, scalable solutions to improve healthcare globally. The company’s founders started 99DOTS in 2013 working with a group of researchers with a history of low-cost innovations for development. Since then, Everwell has partnered intimately with the Indian government as well as NGOs, hospitals, and research groups globally working in Tuberculosis and HIV treatment. The team comprises engineers, user experience researchers, and training and capacity building professions with years of experience and expertise in adherence, technology, and scaling innovations in partnership with government departments. | |
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Delivery of health services and care Research and Development Technical Assistance Working on Key Populations related to TB |
Other Organization Information | |
| Total number of staff in your organization: | 11 - 25 |
| Number of full-time staff who are directly involved with TB: | 11 - 25 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Other partners |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Network with other partners |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| Everwell develops low-cost ICT solutions to empower patients and programs to better treat TB. We are actively working with the Indian NTP (CTD) on digital adherence solutions like 99DOTS, and renovating the national ICT system for more effective treatment. | |
Geographical Reach | |
| Which country is your headquarters located in: | India |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Ethiopia India Myanmar Philippines Uganda Ukraine United Republic of Tanzania |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: Everwell works on improving care delivery through digital adherence initiatives like 99DOTS, MEMS, and VOT - through implementation of digital adherence tools, patients have more freedom and ownership of treatment and programs can more efficiently reach out to patients in need of additional care. We've been working with the national TB program in India since 2014 for national scale up of 99DOTS, in Myanmar since 2016, and in several new countries in Asia and Africa through TB Reach and Unitaid. Drug-Resistant TB: Through adherence strengthening technologies, patients are more empowered to complete their treatment and take daily medication, preventing the emergence of drug resistant strands of TB. We've been working with the national TB program in India since 2014 for national scale up of 99DOTS, in Myanmar since 2016, and in several new countries in Asia and Africa through TB Reach and Unitaid. TB-HIV: In India, 99DOTS was first piloted in 2016 at scale with the TB-HIV population across 30 high-burden sites in southern India. Based on the success of those pilots, 99DOTS has scaled across India to every TB-HIV patient and increasing populations of TB patients in new sites. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | June 27, 2018 |
| Last updated: | July 11, 2018 |